Pre-Publication draft version. Lat reviewed on 7th July 2017
Cochrane Database Syst Rev. 2016 Jul 1; (6): 1–61 -Published online 2016 July 1
This toolkit has been developed by the ZAZI campaign for use by peer educators, community outreach workers, faith-based organisations, and traditional health practitioners to help facilitate participatory discussions on sexual and reproductive health with women aged between 20 and 49 years of age. T...he toolkit is divided in 10 content sections
more
How the Greek reception system is failing to protect the most vulnerable people seeking asylum.
Greece and its EU partners are failing pregnant women, unaccompanied children, victims of torture or sexual violence and other vulnerable people who seek protection in Europe. These people are being put ...at risk by flawed processes and chronic understaffing in EU ‘hotspot’ camps on the Greek islands. They do not receive adequate support from the authorities that are legally responsible for protecting them and are being abandoned in overcrowded camps in squalid conditions. Many people live in unheated tents and do not have sufficient access to washing facilities and toilets, and winter is only making their situation worse
more
Special issue: Mental Health Challenges in Lithuania
Nos. 1-2 '11
This document has been developed to support countries to develop and strengthen peer support groups in mental health and related areas. It addresses the provision of peer support groups in the context of health services and the wider community.
This training and guidance has been developed to provide an in-depth understanding on what it means to respect legal capacity in mental health and related areas as well as concrete strategies to ensure that people are able to exercise their right to legal capacity in all areas of their life. In this... context a wide range of scenarios are used to describe how different models of supported decision making can be applied in practice.
more
Journal des anthropologues n° 138-139, 2014
http://journals.openedition.org/jda/4444
Le médicament pharmaceutique industriel est un objet de santé
à la fois scientifique, populaire et marchand. Si ces deux premiers
caractères sont souvent mis en avant respectivement par les sciences
biom...édicales et pharmaceutiques, par la santé publique ainsi qu’à
travers les médias, sa troisième composante est plus souvent passée
sous silence. Elle tend à être dissimulée derrière ce qui est présenté
comme la vocation première du médicament, à savoir la santé des
individus, leur bien-être physique et psychique. Or, le caractère
marchand du médicament est un formidable vecteur de dynamiques
et d’initiatives. Il est peut-être ce qui explique avant tout
l’incroyable vitalité du secteur pharmaceutique de par la planète,
non sans poser de nombreux problèmes d’ordre sanitaire et de santé
publique.
more
DHS Working Papers No. 113